J Liver Cancer Search


J Liver Cancer > Volume 16(2); 2016 > Article
Journal of Liver Cancer 2016;16(2):129-133.
DOI: https://doi.org/10.17998/jlc.16.2.129    Published online September 30, 2016.
A Case of Management for Hepatocellular Carcinoma with Lung Metastasis
Han Jo Jeon1, Tae Hyung Kim1, Soon Ho Um1, Yeon Seok Seo1, Hyun Seo Kim1, Ki Joon Lim1, Seung Woon Park1, Han Ah Lee1, Dong-Sik Kim2
1Departments of Internal Medicine, Korea University Anam Hospitial, Seoul, Korea
2Departments of Surgery, Korea University Anam Hospitial, Seoul, Korea
Correspondence:  Tae Hyung Kim,
Email: lacid@korea.ac.kr
Copyright ©2016 by The Korean Liver Cancer Association
Liver cancer is the 2nd most common cause of cancer related death in Korea. Especially, patients who present extrahepatic spread of hepatocellular carcinoma (HCC) have a shorter life expectancy (50% survival at 1 year and less than 4 months of median overall survival). Molecular target agent like sorafenib was usually mentioned as a treatment for them, but that was still not firmly established. We present a 75 year-old who had expanding nodular type of HCC. The mass was removed by resection and radiofrequency ablation. However, lung metastasis were revealed shortly after surgery. That lesions were treated with lenvatinib and systemic chemotherapy.
Key Words: Hepatocellular carcinoma; Metastasis; Molecular targeted therapy; Chemotherapy

Editorial Office
1521 Gangnam Finance Plaza (FASTFIVE), 419 Teheran-ro, Gangnam-gu, Seoul 06160, Korea
Tel: +82-2-313-1900    E-mail: liver@klcsg.or.kr                

Copyright © 2021 by The Korean Liver Cancer Association.

Developed in M2PI

Close layer
prev next